Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dongwoon Han has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIb Clinical Trial Evaluating the Efficacy and Safety of Mecasin (KCHO-1) in Adults with Amyotrophic Lateral Sclerosis

    by Joonyoung Shin, Hyorin Lee, Tae Seong Jeong, Eunhye Cha, Wookcheol Seo, Boncho Ku, Ilhong Son, Hyung Won Kang, Dongwoung Kim, Bongkeun Song, et al.

    Background/Objectives: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive muscle weakness and paralysis, with respiratory failure being the leading cause of death. Mecasin (KCHO-1), a standardized botanical extract, has demonstrated neuroprotective and anti-neuroinflammatory effects in preclinical studies. A 12-week phase IIa trial suggested a potential benefit in slowing functional decline. This phase IIb trial evaluated the efficacy and safety of Mecasin over 24 weeks, including respiratory-related outcomes. Methods: In this multicenter, randomized, double-blind, placebo-controlled trial, 50 patients were randomized to receive Mecasin (2.4 g/day) or placebo for 24 weeks, with both groups receiving riluzole (100 mg/day). Forty-three patients were included in the efficacy analysis. The primary endpoint was change in the Korean version of the ALS Functional Rating Scale-Revised (K-ALSFRS-R) total score. Respiratory-related assessments included orthopnea, FEV1/FVC, and end-tidal CO2, alongside safety evaluations. Results: At week 24, K-ALSFRS-R changes were −3.65 and −3.74 points in the Mecasin and placebo groups, respectively, with no significant between-group difference (estimated difference, 0.27; 90% CI, −1.80 to 2.33; p = 0.4146). Significant between-group differences were observed in FEV1/FVC (7.69 percentage points; p = 0.0036) and end-tidal CO2 (−3.92 mmHg; p = 0.0076). Linear mixed-effects models showed significant group-by-visit interactions for orthopnea (p = 0.0212) and FEV1/FVC (p = 0.0228). Adverse-event frequencies were comparable. Conclusions: Although Mecasin did not show a significant effect on the primary outcome (K-ALSFRS-R total score), the observed differences in respiratory-related outcomes provide a clinical rationale for further investigation in larger trials focusing on respiratory function.

  • Open Access

    The Extract of Salvia miltiorrhiza ‘Hongdan’ Attenuates Inflammation in LPS-Activated BV2 Microglia via ERK1/2, JNK, and p38 MAPK Signaling Inhibition

    by Suk Ju, Joonyoung Shin, Hyorin Lee, Gwang Joo Jeon, Dongwoon Han, Sungchul Kim

    Background/Objectives: Salvia miltiorrhiza is a medicinal plant rich in phenolic acids and tanshinones, compounds that have been linked to anti-inflammatory and neuroprotective activities. ‘Hongdan’ is a Korean cultivar characterized by relatively high levels of salvianolic acid B and tanshinone IIA, but its anti-inflammatory activity in microglial cells has not yet been examined. Methods: Nitrite production and the mRNA expression of inflammatory mediators (iNOS and COX-2) and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) were examined. In addition, activation of MAPK (ERK1/2, JNK, and p38) signaling pathway and expression of the NF-κB regulatory protein IκB-α were analyzed. Results: The Hongdan extract inhibited nitrite production and reduced the expression of iNOS and COX-2 in LPS-stimulated BV2 microglial cells. In addition, the expression of IL-1β and IL-6 was markedly reduced, whereas TNF-α was significantly suppressed only at the highest concentration tested. Furthermore, phosphorylation of ERK1/2, JNK, and p38 was significantly inhibited, while IκB-α degradation was not altered. Conclusions: These findings demonstrate that the Hongdan extract effectively suppresses LPS-induced inflammatory responses through inhibition of MAPK signaling pathways and may serve as a promising natural therapeutic candidate for neuroinflammatory disorders.

  • Open Access

    Complementary and alternative medicine use among elderly cancer patients: a cross-sectional study in South Korea

    by Hyunyem Chang, Soo Jeung Choi, Hyea Bin Im, Dain Choi, Dongwoon Han

    Introduction: The use of complementary and alternative medicine (CAM) is common among elderly male cancer patients; however, evidence is limited on its prevalence, characteristics, and determinants in Korea. This study examined the prevalence, patterns, and reasons for CAM use, and identified factors associated with its use among elderly male cancer survivors. Materials and methods: A cross-sectional survey was conducted with 420 cancer patients aged ≥65 years attending outpatient clinics of the Veterans Hospital System, a 1,000-bed secondary hospital in Seoul, Korea. Data on CAM utilization, modalities, reasons for use, and information sources were collected using structured questionnaires. Multivariate logistic regression was used to identify demographic and clinical factors associated with CAM use. Results: Among participants, 60.0% reported using CAM. The most common modalities were exercise (brisk walking, 49.4%) and dietary interventions (42.9%). The primary reason for use was immune enhancement (61.6%), and family members or relatives were the main information source (42.1%). Multivariate analysis revealed that being married (OR 2.49, 95% CI 1.40–4.45), having prostate cancer (OR 2.14, 95% CI 1.36–3.35), and undergoing surgery (OR 1.62, 95% CI 1.07–2.45) were significantly associated with CAM use. Conclusion: CAM use is highly prevalent among elderly male Korean cancer patients, particularly among married men, prostate cancer patients, and those who have undergone surgery. Oncologists should incorporate discussions about CAM into survivorship care, and further studies are warranted to assess the impact of CAM modalities on quality of life and clinical outcomes.

  • Open Access

    Complementary and Alternative Medicine (CAM) Use among Elderly Cancer Patients: A cross- sectional study in South Korea

    by Hyunyem Chang, Soo Jeung Choi, Hyea Bin Im, Dain Choi, Dongwoon Han

    Purpose Complementary and alternative medicine (CAM) use is common among elderly cancer patients, but evidence on its prevalence, characteristics, and determinants in Korea is limited. This study aimed to examined prevalence, patterns, reasons, and associated factors of CAM use among elderly cancer survivors. Materials and Methods A cross-sectional survey was conducted with 420 cancer patients aged ≥ 65 years attending outpatient clinics of the Veterans Hospital System, a 1,000-bed secondary hospital in Seoul, Korea. Data on CAM utilization, modalities, reasons for use, and information sources were collected through structured questionnaires. Multivariate logistic regression was used to identify demographic and clinical factors associated with CAM use. Results Among participants, 60.0% reported CAM use. The most common modalities were exercise (fast walking, 49.4%) and dietary interventions (42.9%). The primary reason was immune enhancement (61.6%), and family members or relatives were the main information source (42.1%). Multivariate analysis revealed that being married (OR 2.49, 95% CI 1.40–4.45), having prostate cancer (OR 2.14, 95% CI 1.36–3.35), and undergoing surgery (OR 1.62, 95% CI 1.07–2.45) were significantly associated with CAM use.. Conclusion CAM use is highly prevalent among elderly Korean cancer patients, particularly in married men, prostate cancer patients, and those who have undergone surgery. Oncologists should incorporate CAM-related discussions into survivorship care, and further studies are warranted to assess the impact of CAM modalities on quality of life and clinical outcomes.

  • Open Access

    Use of acupuncture among chronic disease patients attending primary healthcare facilities: a cross-sectional study in Korea

    by Su Yeon Lee, Soo Jeung Choi, Hyea Bin Im, Dain Choi, Dongwoon Han

    Given the crucial role of integrating acupuncture treatment into primary care for managing chronic diseases, this study endeavors to identify the utilization of acupuncture among chronic disease patients seeking primary care services in Korea. Additionally, it aims to evaluate their knowledge level and perceptions related to acupuncture use. A descriptive cross-sectional study was conducted among chronic disease patients attending a primary care clinic in Korea. A self-reported questionnaire comprising 37 items was employed to evaluate the utilization of acupuncture treatment. These items covered socio-demographic information, respondents’ health status, levels of acupuncture knowledge, and patterns of acupuncture use. Using the SPSS Statistics 26.0 Network Version program, descriptive statistics, a chi-square test, and a logistic regression analysis were performed to identify factors associated with acupuncture treatment. Out of 370 respondents, 44.3% reported utilizing acupuncture treatment. The most popular reason for the utilization of acupuncture was to enhance the effectiveness of the current treatment. The patients with musculoskeletal disease had the highest utilization rate of 53.2%. The main source of information for acupuncture use was family and friends. The average score for the level of knowledge on acupuncture treatment among the respondents was 65.4%, and the knowledge level of the acupuncture group was high. Potential predictors of acupuncture use included musculoskeletal disease, and intention to recommend acupuncture. This study highlights the widespread acceptance of acupuncture use among patients with chronic diseases in primary healthcare context. Integration of acupuncture into primary care emerges as a viable avenue for effective chronic disease management, and fostering a comprehensive and holistic approach to healthcare. Not applicable.


  • Analysis of key pathways and genes in nodal structure on rat skin surface using gene ontology and KEGG pathway

    by Joonyoung Shin, A. Yeong Park, Suk Ju, Hyorin Lee, Hyung Won Kang, Dongwoon Han, Sungchul Kim

    Background We have previously reported anatomical, histological, and gene expression characteristics of the nodal structure of rat skin surface and suggested its potential as an acupuncture point. However, the specific characteristics of the interactions among the genes expressed in this structure remain unclear. Objective We aimed to determine gene expression changes by analyzing interaction networks of genes up-regulated in nodal structures and to explore relationships with acupuncture points. Methods We investigated the relationship between the nodal structures and acupuncture points by analyzing the interactions of up-regulated genes, their Gene Ontology biological functions, and the characteristics of Kyoto Encyclopedia of Genes and Genomes pathways. RNA-seq and STRING analysis provided comprehensive information on these gene groups. Results Interactions between up-regulated genes in nodal structures were classified into three groups. The first group, which includes Wnt7b, Wnt3, and Wnt16, showed significant interactions in pathways such as Wnt signaling, Alzheimer’s disease, and regulation of stem cell pluripotency. The second group, composed of Fos, Dusp1, Pla2g4e, Pla2g4f, and Fgfr3, demonstrated a notable association with the MAPK signaling pathway. Lastly, the third group, consisting of Adcy1, Pla2g4e, Pla2g4f, and Dusp1 exhibited effective interactions with the inflammatory mediator regulation of TRP channels and serotonergic synapse. Conclusion Continued research on nodal structures where these genes are expressed is needed to improve our understanding of skin anatomy and physiology as well as their potential clinical utility as acupuncture points.


  • Open Access

    Antidepressant-like Effects of Cannabis sativa L. Extract in an Lipopolysaccharide Model: Modulation of Mast Cell Activation in Deep Cervical Lymph Nodes and Dura Mater

    by Joonyoung Shin, Dong-Uk Kim, Gi-Sang Bae, Ji-Ye Han, Do-Won Lim, Young-Mi Lee, Eunjae Kim, Eunjeong Kwon, Dongwoon Han, Sungchul Kim

    Background: Lipopolysaccharide (LPS)-induced neuroinflammation is a well-established model for studying depression-like behavior, driven by pro-inflammatory cytokines such as TNF-α and IL-1β. Mast cells (MCs) contribute to neuroinflammation by releasing mediators that exacerbate depressive-like symptoms. This study evaluates the antidepressant-like and anti-inflammatory effects of Cannabis sativa L. inflorescence extract (CSL) in an LPS-induced neuroinflammation model. Methods: Male C57BL/6 mice were intraperitoneally injected with CSL at doses of 10, 20, and 30 mg/kg, 30 min prior to LPS (0.83 mg/kg) administration. Depressive behaviors were assessed using the sucrose preference test (SPT), tail suspension test (TST), and forced swimming test (FST). The neutrophil-to-lymphocyte ratio (NLR) was measured to assess systemic inflammation. Cytokine levels in the prefrontal cortex (PFC) were measured, and mast cell degranulation in the lymph nodes and dura mater was analyzed histologically (approval number: WKU24-64). Results: CSL significantly improved depressive-like behaviors and decreased the NLR, indicating reduced systemic inflammation. CSL also significantly reduced TNF-α and IL-1β levels in the PFC. Furthermore, CSL inhibited MC degranulation in the deep cervical lymph nodes and dura mater, with the strongest effects observed at 30 mg/kg. Conclusions: CSL demonstrated antidepressant-like and anti-inflammatory effects in an LPS-induced neuroinflammation model, likely through the modulation of cytokine expression and mast cell activity. These results suggest the potential of CSL as a therapeutic option for treating inflammation-related depression.


  • Open Access

    Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis

    by Soojeung Choi, Sangita Karki Kunwor, Hyeabin Im, Dain Choi, Junghye Hwang, Mansoor Ahmed, Dongwoon Han

    Globally, cancer patients frequently use T&CM during their treatment for various reasons. The primary concerns regarding the use of T&CM among cancer patients are the potential risks associated with interactions between pharmaceuticals and T&CM, as well as the risk of noncompliance with conventional cancer treatments. Despite the higher prevalence of T&CM use in Asia, driven by cultural, historical, and resource-related factors, no prior review has tried to estimate the prevalence and influencing factors of T&CM use and disclosure among cancer patients in this region. This study aims to examine the prevalence and disclosure rates of T&CM use among cancer patients in Asia to assess various factors influencing its use across different cancer treatment settings in Asia. Systematic research on T&CM use was conducted using four databases (PubMed, EMBASE, Web of Science, and CINAHAL) from inception to January 2023. Quality was assessed using the Appraisal Tool for Cross-Sectional Studies (AXIS). A random effects model was used to estimate the pooled prevalence of T&CM use, and data analysis was performed using Stata Version 16.0. Among the 4849 records retrieved, 41 eligible studies conducted in 14 Asian countries were included, involving a total of 14,976 participants. The pooled prevalence of T&CM use was 49.3%, ranging from 24.0% to 94.8%, and the disclosure rate of T&CM use was 38.2% (11.9% to 82.5%). The most commonly used T&CM modalities were herbal medicines and traditional medicine. Females were 22.0% more likely to use T&CM than males. A subgroup analysis revealed the highest prevalence of T&CM use was found in studies conducted in East Asia (62.4%) and those covered by both national and private insurance (55.8%). The disclosure rate of T&CM use to physicians remains low. Moreover, the factors influencing this disclosure are still insufficiently explored. Since the disclosure of T&CM use is a crucial indicator of patient safety and the quality of cancer treatment prognosis, future research should focus on identifying the determinants of non-disclosure.


  • Open Access

    In Vitro and In Vivo Anti-Inflammatory and Antidepressant-like Effects of Cannabis sativa L. Extracts

    by Joonyoung Shin, Sangheon Choi, A Yeong Park, Suk Ju, Bitna Kweon, Dong-Uk Kim, Gi-Sang Bae, Dongwoon Han, Eunjeong Kwon, Jongki Hong, et al.

    Cannabis sativa L. has been widely used by humans for centuries for various purposes, such as industrial, ceremonial, medicinal, and food. The bioactive components of Cannabis sativa L. can be classified into two main groups: cannabinoids and terpenes. These bioactive components of Cannabis sativa L. leaf and inflorescence extracts were analyzed. Mice were systemically administered 30 mg/kg of Cannabis sativa L. leaf extract 1 h before lipopolysaccharide (LPS) administration, and behavioral tests were performed. We conducted an investigation into the oxygen saturation, oxygen tension, and degranulation of mast cells (MCs) in the deep cervical lymph nodes (DCLNs). To evaluate the anti-inflammatory effect of Cannabis sativa L. extracts in BV2 microglial cells, we assessed nitrite production and the expression levels of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α. The main bioactive components of the Cannabis sativa L. extracts were THCA (a cannabinoid) and β-caryophyllene (a terpene). Cannabis sativa L. leaf extract reduced the immobility time in the forced swimming test and increased sucrose preference in the LPS model, without affecting the total distance and time in the center in the open field test. Additionally, Cannabis sativa L. leaf extract improved oxygen levels and inhibited the degranulation of MCs in DCLNs. The Cannabis sativa L. extracts inhibited IL-1β, IL-6, TNF-α, nitrite, iNOS, and COX-2 expression in BV2 microglia cells. The efficacy of Cannabis sativa L. extracts was suggested to be due to the entourage effect of various bioactive phytochemicals. Our findings indicate that these extracts have the potential to be used as effective treatments for a variety of diseases associated with acute inflammatory responses.


  • Open Access

    Safety classification of herbal medicine use among hypertensive patients: a systematic review and meta-analysis

    by Dain Choi, Hyea Bin Im, Soo Jeung Choi, Dongwoon Han

    Background: The use of herbal medicines (HMs) for the treatment of hypertension (HTN) is increasing globally, but research on the potential adverse effects and safety of HMs in HTN patients is limited. Therefore, this systematic review and meta-analysis aim to determine the global prevalence of HM usage among HTN patients and assess the safety of identified herbs based on current scientific evidence.Methods: The PubMed/MEDLINE, EMBASE (Ovid), and Cumulated Index to Nursing and Allied Health Literature (CINAHL) databases were searched for cross-sectional studies on the use of HM among HTN patients. Our review includes studies published in English up to the year 2023. After extracting and appraising the data from the studies, a meta-analysis was conducted using the Stata version 16.0 to estimate the pooled prevalence of HM use in patients with HTN (PROSPERO: CRD42023405537). The safety classification of the identified HM was done based on the existing scientific literature.Results: This study analyzed 37 cross-sectional studies from 21 countries and found that 37.8% of HTN patients used HM to manage their health. The prevalence of HM use varied significantly based on publication year and geographical region. Among the 71 identified herbs, Allium sativum L., Hibiscus sabdariffa L., and Olea europaea L. were the most commonly used. However, four herbs were identified as contraindicated, 50 herbs required caution, and only 11 herbs were considered safe for use.Conclusion: The study highlights the potential risks of toxicities and adverse effects associated with HM use in the treatment of HTN. Ensuring patient safety involves using safe HMs in appropriate doses and avoiding contraindicated HMs. Future research should focus on identifying commonly used herbs, especially in resource-limited countries with poor HTN management, and additional clinical research is required to assess the toxicity and safety of commonly used HMs.